Dose Ranging Safety and Efficacy of Therapeutic HSV-2 Vaccine

Clinical trial NCT02114060 · COMPLETED

Trial details

NCT number: NCT02114060
Sponsor: Genocea Biosciences, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Genital Herpes Simplex Type 2

Start date: 2014-07-01
Primary completion: 2016-02-01
Enrollment: 310

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.